Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Molecular Insight drug receives orphan designation
With orphan drug designation, Ultratrace MIBG is eligible to receive up to seven years of exclusivity in the US following marketing approval, as well as tax credits for
With orphan drug designation, Ultratrace MIBG is eligible to receive up to seven years of exclusivity in the US following marketing approval, as well as tax credits for
“This collaboration with the CDC illustrates the progress we continue to make with our infectious disease program,” said Steven Porter, chairman & CEO of Ceragenix. “Working with the
Revenues from the company’s asthma drug Advair rose 22% to exceed GBP3 billion in 2005, despite a proposal by US regulators in November 2005 that the drug should
Recent UK press reports explain how a team of researchers at the University of Georgetown discovered that a natural chemical found in foods such as broccoli, cauliflower, cabbage
The drug will now be available to patients and physicians in a 2 mg tablet strength and as a nonrefrigerated oral solution. Previously the drug was only available
The companies were conducting the trial in an attempt to provide additional data to satisfy the FDA after the US regulators indicated in July last year that it
In this first part of the phase III program, 105 patients will be involved in an open-label study to evaluate the efficacy of Mycobacterial cell wall-DNA complex (MCC)
Xyotax is a biologically-enhanced version of Bristol-Myers Squibb’s anticancer drug Taxol, often used in the treatment of ovarian, breast, and non-small cell lung cancer (NSCLC). Fast track designation
This trial is a multi-center, double-blind, placebo-controlled, four-way crossover trial designed to assess the efficacy, tolerability and pharmacokinetics of bicifadine alone and in combination with ibuprofen. Dov expects
The phase I clinical trial triggers a $5 million milestone payment to Arena under its collaboration with Ortho-McNeil to develop compounds targeting the glucose-dependent insulinotropic receptor, or GDIR.